Receptors and tropisms of envelope viruses

Current Opinion in Virology

Volumn 1, Issue 1, 2011, Pages 13-18

  Morizono, Kouki ^a,b   Chen, Irvin S Y ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; VIRUS PROTEIN; VIRUS RECEPTOR; VIRUS VECTOR;

ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; ENDOCYTOSIS; HOST RANGE; HUMAN IMMUNODEFICIENCY VIRUS; IN VIVO STUDY; INFLUENZA VIRUS; NONHUMAN; PH; PROTEIN BINDING; TARGET CELL; VIRAL TROPISM; VIRUS ENTRY;

EID: 79960466427     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2011.05.001     Document Type: Article

References (48)

1. Norkin LC: Virology, Molecular Biology and Pathogenesis. ASM press; 2010.
2. Fields BN, Knipe DM, Howley PM: Fields' Virology. edn 5. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2007.
3. White JM, Delos SE, Brecher M, Schornberg K: Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 2008, 43:189-219. (Pubitemid 351883153)
4. Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JA: Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 2000, 103:679-689.
5. Nicola AV, McEvoy AM, Straus SE: Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol 2003, 77:5324-5332. (Pubitemid 36460946)
6. Naldini L: Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet 2011, 12:301-315.
7. Mueller C, Flotte TR: Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 2008, 15:858-863. (Pubitemid 351712619)
8. Liu TC, Kirn D: Gene therapy progress and prospects cancer: oncolytic viruses. Gene Ther 2008, 15:877-884. (Pubitemid 351791475)
9. Wiley DC, Skehel JJ: The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 1987, 56:365-394.
10. Wilson IA, Skehel JJ, Wiley DC: Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981, 289:366-373.
11. Xu R, Wilson IA: Structural characterization of an early fusion intermediate of influenza virus hemagglutinin. J Virol 2011, 85:5172-5182.
12. Viswanathan K, Chandrasekaran A, Srinivasan A, Raman R, Sasisekharan V, Sasisekharan R: Glycans as receptors for influenza pathogenesis. Glycoconj J 2010, 27:561-570.
13. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody SL: Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 2006, 80:7469-7480. (Pubitemid 44092569)
14. Ohno K, Sawai K, Iijima Y, Levin B, Meruelo D: Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat Biotechnol 1997, 15:763-767. (Pubitemid 27329479)
15. •].
16. •], we can see how E2 and E1 dissociate to initiate exposure of the E1 fusion peptide.
17. Sanchez-San Martin C, Liu CY, Kielian M: Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol 2009, 17:514-521.
18. Bergman I, Whitaker-Dowling P, Gao Y, Griffin JA: Preferential targeting of vesicular stomatitis virus to breast cancer cells. Virology 2004, 330:24-33. (Pubitemid 39446564)
19. Morizono K, Bristol G, Xie YM, Kung SK, Chen IS: Antibodydirected targeting of retroviral vectors via cell surface antigens. J Virol 2001, 75:8016-8020. (Pubitemid 32743673)
20. Morizono K, Xie Y, Ringpis GE, Johnson M, Nassanian H, Lee B, Wu L, Chen IS: Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med 2005, 11:346-352. (Pubitemid 40460565)
21. Morizono K, Pariente N, Xie Y, Chen IS: Redirecting lentiviral vectors by insertion of integrin-tageting peptides into envelope proteins. J Gene Med 2009, 11:549-558.
22. Morizono K, Ku A, Xie Y, Harui A, Kung SK, Roth MD, Lee B, Chen IS: Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins. J Virol 2010, 84:6923-6934.
23. Yang L, Bailey L, Baltimore D, Wang P: Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci USA 2006, 103:11479-11484. (Pubitemid 44182477)
24. Morizono K, Xie Y, Helguera G, Daniels TR, Lane TF, Penichet ML, Chen IS: A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. J Gene Med 2009, 11:655-663.
25. Landau NR, Warton M, Littman DR: The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature 1988, 334:159-162.
26. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877. (Pubitemid 26154590)
27. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM et al.: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666. (Pubitemid 26197679)
28. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, Kewal Ramani VN, Littman DR et al.: DC-SIGN, a dendritic cellspecific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
29. Lee B, Leslie G, Soilleux E, O'Doherty U, Baik S, Levroney E, Flummerfelt K, Swiggard W, Coleman N, Malim M et al: cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol 2001, 75:12028-12038. (Pubitemid 33115875)
30. Kasahara N, Dozy AM, Kan YW: Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994, 266:1373-1376.
31. Zhao Y, Zhu L, Lee S, Li L, Chang E, Soong NW, Douer D, Anderson WF: Identification of the block in targeted retroviralmediated gene transfer. Proc Natl Acad Sci USA 1999, 96:4005-4010. (Pubitemid 29169026)
32. Dorig RE, Marcil A, Chopra A, Richardson CD: The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993, 75:295-305. (Pubitemid 23320293)
33. Tatsuo H, Ono N, Tanaka K, Yanagi Y: SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000, 406:893-897. (Pubitemid 30664265)
34. Hashiguchi T, Ose T, Kubota M, Maita N, Kamishikiryo J, •• Maenaka K, Yanagi Y: Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol 2011, 18:135-141. This study presented the crystal structure of the measles virus H protein bound to CD150, which could represent the initial structural change of the H protein to elicit signals that trigger the conformational change of F.
35. Navaratnarajah CK, Oezguen N, Rupp L, Kay L, Leonard VH, •• Braun W, Cattaneo R: The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol 2011, 18:128-134. This study attempted to elucidate how the measles virus H protein conformational change occurs after binding to CD150 by introducing mutations into H proteins. This study also identified the regions of the H protein that can elicit signals to trigger fusion activity of the F protein after binding to target antigens.
36. Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IA, James CD, Russell SJ: Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol 2005, 23:209-214. (Pubitemid 40255331)
37. Funke S, Maisner A, Muhlebach MD, Koehl U, Grez M, Cattaneo R, Cichutek K, Buchholz CJ: Targeted cell entry of lentiviral vectors. Mol Ther 2008, 16:1427-1436.
38. de Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TB: Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 2006, 80:3477-3486.
39. Morizono K, Xie Y, Olafsen T, Lee B, Dasgupta A, Wu AM, Chen IS: •• The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host Microbe 2011, 9:286-298. This study demonstrated that pseudotyped lentiviral vectors and replication-competent vaccinia virus utilize a cellular mechanism for their entry that is typically used to remove dead cells.
40. Nagata S, Hanayama R, Kawane K: Autoimmunity and the clearance of dead cells. Cell 2010, 140:619-630.
41. Mercer J, Helenius A: Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 2008, 320:531-535. (Pubitemid 351590666)
42. Callahan MK, Popernack PM, Tsutsui S, Truong L, Schlegel RA, Henderson AJ: Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells. J Immunol 2003, 170:4840-4845. (Pubitemid 36519995)
43. Soares MM, King SW, Thorpe PE: Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases. Nat Med 2008, 14:1357-1362.
44. Hafizi S, Dahlback B: Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 2006, 273:5231-5244. (Pubitemid 44772384)
45. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, Jones S, Feldmann H, Kawaoka Y: Tyro3 familymediated cell entry of Ebola and Marburg viruses. J Virol 2006, 80:10109-10116. (Pubitemid 44522604)
46. Kuritzkes DR: HIV-1 entry inhibitors: an overview. Curr Opin HIV AIDS 2009, 4:82-87.
47. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A et al.: Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007, 131:1059-1071. (Pubitemid 350235017)
48. Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J: The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proc Natl Acad Sci USA 2009, 106:9033-9038.